The weekly litigation news digest is live. Subscribe now

IP Verse

Prolyl Hydroxylase Inhibitors And Methods Of Use - EP3357911

The patent EP3357911 was granted to Akebia Therapeutics on May 11, 2022. The application was filed on Jun 26, 2007 under application number EP18158907A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3357911

AKEBIA THERAPEUTICS
Application Number
EP18158907A
Filing Date
Jun 26, 2007
Status
Granted And Under Opposition
Apr 8, 2022
Publication Date
May 11, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
FIBROGENFeb 13, 2023CARPMAELS & RANSFORDWITHDRAWN

Patent Citations (16) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
OPPOSITIONEP0650960
OPPOSITIONEP0650961
OPPOSITIONUS5607954
OPPOSITIONUS5610172
OPPOSITIONUS5620995
OPPOSITIONUS5620996
OPPOSITIONUS5668933
OPPOSITIONUS5719164
OPPOSITIONUS5726305
OPPOSITIONUS6020350
OPPOSITIONUS6093730
OPPOSITIONWO03049686
OPPOSITIONWO03053997
OPPOSITIONWO2004108121
SEARCHWO03049686
SEARCHWO03053997

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents